Glenn A. Eisenberg - 11 Feb 2025 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Feb 2025, 11:39:32 UTC
Prior SEC filing
10 Feb 2025
Next SEC filing
31 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Glenn A. Eisenberg

Key filing fact

Glenn A. Eisenberg filed Form 4 for LABCORP HOLDINGS INC. (LH) on 13 Feb 2025.

Key facts

  • This page summarizes Glenn A. Eisenberg's Form 4 filing for LABCORP HOLDINGS INC. (LH).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 13 Feb 2025, 11:39.

Change

  • Previous filing in this sequence was filed on 10 Feb 2025.
  • Current net transaction value: -$52,215.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LH transaction

Common Stock

Options Exercise

Transaction value
Shares
+807
Change %
+2.5%
Price
Shares after
33,458
Date
11 Feb 2025
Ownership
Direct
Footnotes
F1
LH transaction

Common Stock

Tax liability

Transaction value
$52,215
Shares
-213
Change %
-0.64%
Price
$245.14
Shares after
33,245
Date
11 Feb 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LH transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-807
Change %
-22%
Price
$0.000000
Shares after
2,819
Date
11 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
807
Exercise price
Footnotes
F1, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

Footnote F2

Stock withholding to satisfy tax withholding obligations.

Footnote F3

The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.

Footnote F4

This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .